These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32621913)

  • 1. Liraglutide shows superior cardiometabolic benefits than lorcaserin in a novel free choice diet-induced obese rat model.
    Briand F; Brousseau E; Maupoint J; Dubroca C; Costard C; Breyner N; Burcelin R; Sulpice T
    Eur J Pharmacol; 2020 Sep; 882():173316. PubMed ID: 32621913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reductions of food intake and body weight in diet-induced obese rats following chronic treatment with a monomeric peptide multiagonist.
    Elfers CT; Chichura KS; Ashlaw EF; Chepurny OG; Holz GG; Doyle RP; Roth CL
    Clin Nutr; 2024 Jul; 43(7):1782-1790. PubMed ID: 38861891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of liraglutide and sibutramine on food intake, palatability, body weight and glucose tolerance in the gubra DIO-rats.
    Hansen G; Jelsing J; Vrang N
    Acta Pharmacol Sin; 2012 Feb; 33(2):194-200. PubMed ID: 22301859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Hamster Model of Diet-Induced Obesity for Preclinical Evaluation of Anti-Obesity, Anti-Diabetic and Lipid Modulating Agents.
    Dalbøge LS; Pedersen PJ; Hansen G; Fabricius K; Hansen HB; Jelsing J; Vrang N
    PLoS One; 2015; 10(8):e0135634. PubMed ID: 26266945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of GLP-1 Receptor Agonists in the Cardiometabolic Complications in a Rat Model of Postmenopausal PCOS.
    Torres Fernandez ED; Huffman AM; Syed M; Romero DG; Yanes Cardozo LL
    Endocrinology; 2019 Dec; 160(12):2787-2799. PubMed ID: 31593246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liraglutide treatment improves the coronary microcirculation in insulin resistant Zucker obese rats on a high salt diet.
    Sukumaran V; Tsuchimochi H; Sonobe T; Waddingham MT; Shirai M; Pearson JT
    Cardiovasc Diabetol; 2020 Feb; 19(1):24. PubMed ID: 32093680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel insulin sensitizer MSDC-0602K improves insulinemia and fatty liver disease in mice, alone and in combination with liraglutide.
    Kamm DR; Pyles KD; Sharpe MC; Healy LN; Colca JR; McCommis KS
    J Biol Chem; 2021; 296():100807. PubMed ID: 34022222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of WBN/Kob diabetic fatty rats supplemented with a fructose-rich diet as a metabolic syndrome model: response to a GLP-1 receptor agonist.
    Namekawa J; Nemoto S; Sunada G; Takanashi Y; Fujio S; Shirai M; Asai F
    J Vet Med Sci; 2018 Oct; 80(10):1515-1523. PubMed ID: 30175725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tandem mass tag-based proteomic profiling revealed potential therapeutic targets and mechanisms of liraglutide for the treatment of impaired glucose tolerance.
    Guo Q; Han C; Xu Y; Chen Q; Han X; Zhao S; Li J; Lu H
    Front Endocrinol (Lausanne); 2022; 13():1031019. PubMed ID: 36452319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term characterization of the diet-induced obese and diet-resistant rat model: a polygenetic rat model mimicking the human obesity syndrome.
    Madsen AN; Hansen G; Paulsen SJ; Lykkegaard K; Tang-Christensen M; Hansen HS; Levin BE; Larsen PJ; Knudsen LB; Fosgerau K; Vrang N
    J Endocrinol; 2010 Sep; 206(3):287-96. PubMed ID: 20508079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postpartum treatment with liraglutide in combination with metformin versus metformin monotherapy to improve metabolic status and reduce body weight in overweight/obese women with recent gestational diabetes: A double-blind, randomized, placebo-controlled study.
    Elkind-Hirsch KE; Shaler D; Harris R
    J Diabetes Complications; 2020 Apr; 34(4):107548. PubMed ID: 32046931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of metformin and liraglutide cardioprotective effect in rats with impaired glucose tolerance.
    Simanenkova A; Minasian S; Karonova T; Vlasov T; Timkina N; Shpilevaya O; Khalzova A; Shimshilashvili A; Timofeeva V; Samsonov D; Borshchev Y; Galagudza M
    Sci Rep; 2021 Mar; 11(1):6700. PubMed ID: 33758265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses high fat diet-induced obesity and glucose intolerance in Sprague-Dawley rats.
    Hata T; Mera Y; Tadaki H; Kuroki Y; Kawai T; Ohta T; Kakutani M
    Diabetes Obes Metab; 2011 May; 13(5):446-54. PubMed ID: 21255216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipidized PrRP Analog Exhibits Strong Anti-Obesity and Antidiabetic Properties in Old WKY Rats with Obesity and Glucose Intolerance.
    Mráziková L; Hojná S; Vaculová P; Strnad Š; Vrkoslav V; Pelantová H; Kuzma M; Železná B; Kuneš J; Maletínská L
    Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of liraglutide on dietary lipid-induced insulin resistance in humans.
    Koska J; Lopez L; D'Souza K; Osredkar T; Deer J; Kurtz J; Salbe AD; Harman SM; Reaven PD
    Diabetes Obes Metab; 2018 Jan; 20(1):69-76. PubMed ID: 28605158
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Lee JK; Lee JJ; Kim YK; Lee Y; Ha JH
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32664607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary D-psicose reduced visceral fat mass in high-fat diet-induced obese rats.
    Chung YM; Hyun Lee J; Youl Kim D; Hwang SH; Hong YH; Kim SB; Jin Lee S; Hye Park C
    J Food Sci; 2012 Feb; 77(2):H53-8. PubMed ID: 22339545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DR10601, a novel recombinant long-acting dual glucagon-like peptide-1 and glucagon receptor agonist for the treatment of obesity and type 2 diabetes mellitus.
    Wang W; Wen X; Duan W; Wang X; Chen Y; Dong J; Yang Z; Fang J; Zhou Z; Yao G; Fang Y; Huang Y
    J Endocrinol Invest; 2020 May; 43(5):653-662. PubMed ID: 31786794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of liraglutide 3 mg vs structured lifestyle modification on body weight, liver fat and liver function in obese patients with non-alcoholic fatty liver disease: A pilot randomized trial.
    Khoo J; Hsiang J; Taneja R; Law NM; Ang TL
    Diabetes Obes Metab; 2017 Dec; 19(12):1814-1817. PubMed ID: 28503750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of glucose intolerance by by pioglitazone in high fat diet-fed rats.
    Srinivasan K; Patole PS; Kaul CL; Ramarao P
    Methods Find Exp Clin Pharmacol; 2004 Jun; 26(5):327-33. PubMed ID: 15319810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.